Skip to main content
. 2021 Jun 30;22(3):927. doi: 10.3892/etm.2021.10359

Figure 2.

Figure 2

B3GALT5-AS1 silencing and CSNK2A1 overexpression on MKN-cells. (A) Expression levels of B3GALT5-AS1 in MKN-45 cells following transfection with shRNA-NC, shRNA-B3GALT5-AS1-1 or shRNA-B3GALT5-AS1-2 were determined by RT-qPCR. (B) Western blot analysis showing the protein expression levels of CSNK2A1. *P<0.05, **P<0.01 and ***P<0.001 vs. shRNA-NC. (C) mRNA expression levels of CSNK2A1 following transfection with ov-NC or ov-CSNK2A1 were assessed by RT-qPCR. (D) Western blot analysis showing the protein expression levels of CSNK2A1 following transfection of MKN-45 cells with ov-NC or ov-CSNK2A1. **P<0.01 and ***P<0.001 vs. ov-NC. B3GALT5-AS1, β-1,3-galactosyltransferase 5-AS1; CSNK2A1, casein kinase 2 a1; NC, negative control; RT-qPCR, reverse transcription-quantitative PCR; LncRNA, long non-coding RNA; Ov, expression; shRNA, short hairpin RNA.